Posttraumatic epilepsy: What's contusion got to do with it?

Epilepsy Currents

Volumn 12, Issue 3, 2012, Pages 87-91

  Willmore, L James ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; CANNABINOID 1 RECEPTOR ANTAGONIST; DIZOCILPINE; ETIRACETAM; HYDROXYL RADICAL; LAMOTRIGINE; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POLYUNSATURATED FATTY ACID; SINGLET OXYGEN; SUPEROXIDE; VALPROIC ACID;

BRAIN CONTUSION; BRAIN HEMORRHAGE; DISEASE MODEL; EDEMA; EPILEPTOGENESIS; EXTRAVASATION; FORCE; HUMAN; KINDLING; NEUROPROTECTION; NONHUMAN; REVIEW; RISK FACTOR; SKULL INJURY; TRAUMATIC BRAIN INJURY; TRAUMATIC EPILEPSY;

EID: 84870267301     PISSN: 15357597     EISSN: 15357511     Source Type: Journal    
DOI: 10.5698/1535-7511-12.3.87     Document Type: Review

References (58)

1. Feeney DM, Walker AE. The prediction of posttraumatic epilepsy: A mathematical approach. Arch Neurol 1979;36:8-12.
2. Salazar AM, Jabbari B, Vance SC, Grafman J, Amin D, Dillon JD. Epilepsy after penetrating head injury. I. Clinical correlates: A report of the Vietnam Head Injury Study. Neurology 1985;35:1406-1414.
3. Raymont V, Salazar AM, Lipsky R, Goldman D, Tasick G, Grafman J. Correlates of posttraumatic epilepsy 35 years following combat brain injury. Neurology 2010;75:224-229.
4. Englander J, Bushnik T, Duong TT, Cifu DX, Zafonte R, Wright J, Hughes R, Bergman W. Analyzing risk factors for late posttraumatic seizures: A prospective, multicenter investigation. Arch Phys Med Rehabil 2003;84:365-373.
5. Mathern GW, Babb TL, Pretorius JK, Melendez M, Levesque MF. The pathophysiologic relationships between lesion pathology, intracranial ictal EEG onsets, and hippocampal neuron losses in temporal lobe epilepsy. Epilepsy Res 1995;21:133-147.
6. Swartz BE, Houser CR, Tomiyasu U, Walsh GO, DeSalles A, Rich JR, Delgado-Escueta A. Hippocampal cell loss in posttraumatic human epilepsy. Epilepsia 2006;47:1373-1382.
7. Willmore LJ, Sypert GW, Munson JB. Recurrent seizures induced by cortical iron injection: A model of post-traumatic epilepsy. Ann Neurol 1978;4:329-336.
8. Willmore LJ. Posttraumatic epilepsy: Cellular mechanisms and implications for treatment. Epilepsia 1990;31(suppl):S67-S73.
9. Willmore LJ, Hiramatsu M, Kochi H, Mori A. Formation of superoxide radicals, lipid peroxides and edema after FeCl3 injection into rat isocortex. Brain Res 1983;277:393-396.
10. Martins da Silva A, Nunes B, Vaz AR, Mendonca D. Posttraumatic epilepsy in civilians: Clinical and electroencephalographic studies. In: Neurotraumatology: Progress and Perspectives. (Martins da Silva A, Rocha Melo A, Loew P, eds.) Springer-Verlag Wein, New York, 1992:56-63.
11. Messori A, Polonara G, Carle F, Gesuita R, Salvolini U. Predicting posttraumatic epilepsy with MRI: Prospective longitudinal morphologic study in adults. Epilepsia 2005;46:1472-1481.
12. Angeleri F, Majkowski J, Cacchio G, Sobieszek A, D'Acunto S, Gesuita R, Bachleda A, Polonara G, Krolicki L, Signorino M, Salvolini U. Posttraumatic epilepsy risk factors: One-year prospective study after head injury. Epilepsia 1999;40:1222-1230.
13. Payan H, Toga M, Berard-Badier M. The pathology of post-traumatic epilepsies. Epilepsia 1970;11:81-94.
14. Kuchiwaki H, Kobayashi T, Takahashi T, Kitano T, Yoshiko K. Iron in cicatrix and abnormal CT findings in a patient with posttraumatic epilepsy. Neurochirurgia (Stuttg) 1989;32:116-119.
15. Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ. Haydon PG, Coulter DA. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci 2010;13:584-591.
16. Adams JH, Graham DI, Murray LS, Scott G. Diffuse axonal injury due to nonmissile head injury in humans: An analysis of 45 cases. Ann Neurol 1983;12:557-563.
17. Gennarelli TA, Thibaulat LE, Adams JH, Graham DI, Thompson CJ, Marcincin RP. Diffuse axonal injury and traumatic coma in the primate. Ann Neurol 1982;12:564-574.
18. Faught E, Peters D, Bartolucci A, Moore L, Miller PC. Seizures after primary intracerebral hemorrhage. Neurology 1989;39:1089-1093.
19. Aisen P. Some physicochemical aspects of iron metabolism. Ciba Foundation Symposium. New York: Elsevier, 1977:1-14.
20. Fong KL, McCay PB, Poyer JL, Misra HP, Keele BB. Evidence of superoxide-dependent reduction of Fe3+ and its role in enzyme-generated hydroxyl radical formation. Chem Biol Interact 1976;15:77-89.
21. Svingen BA, O'Neal FO, Aust SD. The role of superoxide and singlet oxygen in lipid peroxidation. Photochem Photobiol 1978;28:803-809.
22. Smith GJ, Dunkley WL. Initiation of lipid peroxidation by a reduced metal ion. Arch Biochem Biophys 1962;98:46-48.
23. Willmore LJ, Habu H. Free radicals and posttraumatic epilepsy: Induction and limitation of brain injury responses. In: Free Radicals in Brain Physiology and Disorders. (Packer L, Hiramatsu M, Yoshikawa T, eds.) San Diego: Academic Press, 1996:173-184.
24. McNamara J. Kindling model of epilepsy. Adv Neurol 1986;44:303-318.
25. Sutula T, Harrison C, Steward O. Chronic epileptogenesis induced by kindling of the entorhinal cortex: The role of the dentate gyrus. Brain Res 1986;385:291-299.
26. Ueda Y, Yokoyama H, Nakajima A, Tokumaru J, Doi T, Mitsuyama Y. Glutamate excess and free radical formation during and following acid-induced status epilepticus. Exp Brain Res 2002;147:219-226.
27. Mathern GW, Bertram EH III, Babb TL, Pretorius JK, Kuhlman PA, Spradlin S, Mendoza D. In contrast to kindled seizures, the frequency of spontaneous epilepsy in the limbic status model correlates with greater aberrant fascia dentata excitatory and inhibitory axon sprouting, and increased staining for n-methyl-d-aspartate, AMPA and GABAa receptors. Neuroscience 1997;77:1003-1019.
28. Sutula T. Antiepilepsy drugs to prevent neural degeneration associated with epilepsy: Assessing the prospects for neuroprotection. Epilepsy Res 2002;50:125-129.
29. Stafstrom CE, Ockuly JC, Murphree L, Valley MT, Roopra A, Sutula TP. Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models. Ann Neurol 2009;65:435-447.
30. Pitkanen A, Kharatishvili I, Nissinen J, McIntosh TK. Posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats. In: Models of Seizures and Epilepsy. (Pitkanen A, Schwartzkroin P, Moshe SL, eds.) Amsterdam: Elsevier Academic Press, 2009:465-476.
31. Graber KD, Prince DA. Chronic partial cortical isolation. In: Models of Seizures and Epilepsy. (Pitkanen A, Schwartzkroin P, Moshe S, eds.) San Diego: Elsevier Academic Press, 2006:477-493.
32. Prince DA, Parada I, Scalise K, Graber K, Jin X, Shea F. Epilepsy following cortical injury: Cellular and molecular mechanisms as targets for potential prophylaxis. Epilepsia 2009;50(suppl):30-40.
33. Li H, McDonald W, Prada I, Faria L, Graber K, Takahashi DK, Ma Y, Prince D. Targets for preventing epilepsy following cortical injury. Neurosci Lett 2011;497:163-171.
34. Penry JK, White BG, Brackett CE. A controlled prospective study of the pharmacologic prophylaxis of posttraumatic epilepsy. Neurology 1979;29:600-601.
35. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497-502.
36. Temkin NR, Dikmen SS, Anderson GD, Wilensky AJ, Holmes MD, Cohen W, Newell DW, Nelson P, Awan A, Winn HR. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999;91:593-600.
37. Temkin NR, Anderson GD, Winn HR, Ellenbogen RG, Britz GW, Schuster J, Lucus T, Newell DW, Mansfield PN, Machamer JE, Barber J, Dikemen SS. Magnesium sulfate for neuroprotection after traumatic brain injury: A randomised controlled trial. Lancet Neurol 2007;6:29-38.
38. Pitkanen A. Therapeutic approaches to epileptogenesis: Hope is on the horizon. Epilepsia 2010;51(SUPPL):2-17.
39. Gowers WR. Epilepsy and Other Chronic Convulsive Diseases. London: J & A Churchill, 1881.
40. Foresti ML, Arisa GM, Shapiro LE. Role of glia in epilepsy-associated neuropathology, neuroinflammation and neurogenesis. Brain Res Rev 2011;66:115-122.
41. Chrzaszcz M, Venkatesan C, Dragisic T, Watterson DM, Wainwright MS. Minozac treatment prevents increased seizure susceptibility in a mouse "two-hit" model of closed skull traumatic brain injury and electroconvulsive shock-induced seizures. J Neurotrauma 2010;27:1283-1295.
42. Echegoyen J, Armstrong C, Morgan RJ, Soltesz I. Single application of a CB1 receptor antagonist rapidly following head injury prevents longterm hyperexcitability in a rat model. Epilepsy Res 2009;85:123-127.
43. Wu Z, Xu Q, Zhang L, Kong D, Ma R, Wang L. Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res 2012;34:1393-1400.
44. Ueda Y, Doi T, Tokumaru J, Yokoyama H, Nakajima A, Mitsuyama U, Ohya-Nashiguchi H, Kamada H, Willmore LJ. Collapse of extracellular glutamate regulation during epileptogenesis: Down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid. Exp Brain Res 2001;135:199-203.
45. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB. β-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005;433:73-77.
46. Crino PB. Rapamycin and tuberous sclerosis complex: From Easter Island to Epilepsy. Ann Neurol 2008;63:415-417.
47. McDaniel SS, Wong M. Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis. Neurosci Lett 2011;497:231-239.
48. Zeng LH, Xu L, Gutmann DH, Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 2008;63:444-453.
49. Buckmaster PS, Wen X. Rapamycin suppresses axon sprouting by somatostatin interneurons in a mouse model of temporal lobe epilepsy. Epilepsia 2011;52:2067-2064.
50. Anderson DK, Means ED. Lipid peroxidation in spinal cord: FeCl2 induction and protection with antioxidants. Neurochem Pathol 1983;1:249-264.
51. Willmore LJ, Rubin JJ. Antiperoxidant pretreatment and iron-induced epileptiform discharge in the rat: EEG and histopathologic study. Neurology 1981;31:63-69.
52. Willmore LJ, Rubin JJ. Effects of antiperoxidants on FeCl2-induced lipid peroxidation and focal edema in rat brain. Exp Neurol 1984;83:62-70.
53. Triggs WJ, Willmore LJ. Effect of [dl]-a-tocopherol on FeCl2-induced lipid peroxidation in rat amygdala. Neurosci Lett 1994;180:33-36.
54. Conroy BP, Black D, Lin CY, Jenkins LW, Crumrine RC, DeWitt DS, Johnston WE. Lamotrigine attenuates cortical glutamate release during global cerebral ischemia in pigs on cardiopulmonary bypass. Anesthesiology 1999;90:844-854.
55. Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 1998;284:474-479.
56. Hanon E, Klitgaard H. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 2001;10:287-293.
57. Rigoulot MA, Koning E, Ferrandon A, Nehlig A. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy. J Pharmacol Exp Ther 2004;308:787-795.
58. Minato H, Kikuta C, Fujitani B, Masuda Y. Protective effect of zonisamide, an antiepileptic drug, against transient focal cerebral ischemia with middle cerebral artery occlusion-reperfusion in rats. Epilepsia 1997;38:975-980.